Business Context and Reporting Period
Company: The Scotts Miracle-Gro Company (SMG)
Filing Type: Form 8-K (Current Report)
Reporting Date: April 9, 2026 (Event Date: April 8, 2026)
Context: The Company announced the completion of the sale of its Hawthorne business, a subsidiary focused on nutrients, lighting, and materials for indoor and hydroponic gardening in North America.
Key Financial Metrics
This filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the Company or the sold business. The transaction consideration was structured as equity and warrants rather than cash.
- Transaction Consideration: 213 million subordinate voting shares of Vireo Growth Inc. (Vireo) plus warrants to acquire 80 million additional Vireo shares.
- Accounting Treatment: Results of operations for the Hawthorne business are classified as a discontinued operation effective in the first quarter of fiscal 2026.
Material Changes
The primary material change is the divestiture of the Hawthorne business unit. The transaction closed substantially simultaneously with the signing of the Securities Purchase Agreement on April 8, 2026. Consequently, future financial reporting will exclude Hawthorne's results, which are now presented as discontinued operations.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the strategic exit from the indoor and hydroponic gardening segment via the sale to Vireo Growth Inc. and Prolific Supply LLC.
Risks and Contingencies: The filing does not detail specific risks associated with the transaction beyond standard closing conditions. No forward-looking guidance or outlook for the remaining business is provided in this specific document.
Investor Verification Checklist
- Verify the fair market value of the 213 million Vireo shares and 80 million warrants received at the time of closing.
- Review the Company's subsequent quarterly earnings release to confirm the financial impact of classifying Hawthorne as a discontinued operation.
- Examine the press release (Exhibit 99.1) for details on the strategic rationale and any retained interests in the Hawthorne business.
- Monitor Vireo Growth Inc.'s stock performance to assess the value of the consideration received.